{"id":"W4242040300","doi":"10.1200/jco.2021.39.3_suppl.94","title":"LEAP-005: A phase II multicohort study of lenvatinib plus pembrolizumab in patients with previously treated selected solid tumors—Results from the colorectal cancer cohort.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Lenvatinib; Medicine; Pembrolizumab; Irinotecan; Internal medicine; Colorectal cancer; Oncology; Clinical endpoint; Oxaliplatin; Phases of clinical research; Cancer; Response Evaluation Criteria in Solid Tumors; Clinical trial; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009087814,0.0002698642,0.002705512,0.00008385389,0.0001121833,0.000009081282,0.0001707323,0.0002011588,0.000103359],"category_scores_gemma":[0.003747841,0.0001465277,0.0002461939,0.0005393225,0.0002251827,0.00007853789,0.0001186678,0.0008963515,0.000001018162],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005597643,"about_ca_system_score_gemma":0.003339136,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00191891,"about_ca_topic_score_gemma":0.0133907,"domain_scores_codex":[0.9948998,0.0006884988,0.003033139,0.0004000338,0.0006409475,0.0003375777],"domain_scores_gemma":[0.9934874,0.002320843,0.002145774,0.000247634,0.001581381,0.0002169448],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1052353,0.02442721,0.8428043,0.000009541751,0.002999856,0.0008087348,0.002954197,0.00007024316,0.00004593225,4.300207e-7,0.0005998878,0.02004429],"study_design_scores_gemma":[0.1258382,0.08067504,0.7902893,0.0002077331,0.001497172,0.00002662811,0.0007510992,0.0001222993,0.0001326086,0.000002635511,0.0003480664,0.0001092791],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9963539,0.0005312158,0.000001167369,0.0009929774,0.0003491035,0.001330986,0.00009300664,0.00001060483,0.0003371003],"genre_scores_gemma":[0.9986441,0.000400265,0.0001142899,0.0002867507,0.0003165188,0.00006191005,0.00004371514,0.00002443599,0.0001080384],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05624782,"threshold_uncertainty_score":0.7472323,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05796847535692534,"score_gpt":0.4249226621907886,"score_spread":0.3669541868338633,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}